{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T19:59:57Z","timestamp":1772654397126,"version":"3.50.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.yrtph.2022.105157","type":"journal-article","created":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T11:04:08Z","timestamp":1647083048000},"page":"105157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["A framework to mitigate the risk of chemical leukoderma: Consumer products"],"prefix":"10.1016","volume":"131","author":[{"given":"Donald L.","family":"Bjerke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengde","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumasa","family":"Wakamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shosuke","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiazhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Laughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Hakozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2022.105157_bib1","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1016\/j.jdermsci.2016.08.263","article-title":"A mouse model of leukoderma induced by rhododendrol","volume":"84","author":"Abe","year":"2016","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.yrtph.2022.105157_bib2","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/1346-8138.15534","article-title":"Expression of discoidin domain receptor 1 and E-cadherin in epidermis affects melanocyte behavior in rhododendrol-induced leukoderma mouse model","volume":"47","author":"Abe","year":"2020","journal-title":"J. Dermatol."},{"key":"10.1016\/j.yrtph.2022.105157_bib3","first-page":"2095","article-title":"The first epidemiological report on rhododendrol-induced leukoderma in Japan based on a nationwide survey","volume":"124","author":"Aoyama","year":"2014","journal-title":"Jpn. J. Dermatol."},{"key":"10.1016\/j.yrtph.2022.105157_bib4","article-title":"RIFM fragrance ingredient safety assessment, 4-(p-hydroxyphenyl)-2-butanone, CAS Registry Number 5471-51-2","volume":"134","author":"Api","year":"2019","journal-title":"Food Chem. Toxicol"},{"key":"10.1016\/j.yrtph.2022.105157_bib5","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.yrtph.2016.01.015","article-title":"Linking existing in vitro dermal absorption data to physicochemical properties: contribution to the design of a weight-of-evidence approach for the safety evaluation of cosmetic ingredients with low dermal bioavailability","volume":"76","author":"Ates","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2022.105157_bib6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1600-0749.2004.00130.x","article-title":"On the etiology of contact\/occupational vitiligo","volume":"17","author":"Boissy","year":"2004","journal-title":"Pigm. Cell Res."},{"key":"10.1016\/j.yrtph.2022.105157_bib7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1021\/tx9902082","article-title":"Role of quinones in toxicology","volume":"13","author":"Bolton","year":"2000","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.yrtph.2022.105157_bib8","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/DER.0000000000000167","article-title":"Chemical leukoderma","volume":"27","author":"Bonamonte","year":"2016","journal-title":"Dermatitis"},{"key":"10.1016\/j.yrtph.2022.105157_bib9","doi-asserted-by":"crossref","first-page":"17S","DOI":"10.1177\/1091581816686048","article-title":"Safety assessment of amino acid alkyl amides as used in cosmetics","volume":"36","author":"Burnett","year":"2017","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.yrtph.2022.105157_bib10","series-title":"Amended Safety Assessment of Hydroquinone as Used in Cosmetics","author":"Cosmetic Ingredient Review","year":"2015"},{"key":"10.1016\/j.yrtph.2022.105157_bib11","series-title":"Final Report. Safety Assessment of Saccharide Esters as Used in Cosmetics","author":"Cosmetic Ingredient Review","year":"2017"},{"key":"10.1016\/j.yrtph.2022.105157_bib12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/10408449991349221","article-title":"The toxicology of hydroquinone \u2013 relevance to occupational and environmental exposure","volume":"29","author":"DeCaprio","year":"1999","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2022.105157_bib13","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000211294","article-title":"Development of an in vitro primary screen for skin depigmentation and antimelanoma agents","volume":"7","author":"Dooley","year":"1994","journal-title":"Skin Pharmacol"},{"key":"10.1016\/j.yrtph.2022.105157_bib14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/10408363.2013.805182","article-title":"Pterostilbene: biomedical applications","volume":"50","author":"Estrela","year":"2013","journal-title":"Crit. Rev. Clin. Lab Sci."},{"key":"10.1016\/j.yrtph.2022.105157_bib15","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0190-9622(82)80023-6","article-title":"Can bleaching creams containing 2% hydroquinone produce leukoderma?","volume":"7","author":"Fisher","year":"1982","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.yrtph.2022.105157_bib16","doi-asserted-by":"crossref","first-page":"61S","DOI":"10.1177\/1091581818794455","article-title":"Safety assessment of tocopherols and tocotrienols as used in cosmetics","volume":"37","author":"Fiume","year":"2018","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.yrtph.2022.105157_bib17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1539\/joh.40.97","article-title":"An experimental study on depigmenting activity of 4-(p-hydroxyphenyl)-2-butanone in C57 black mice","volume":"40","author":"Fukuda","year":"1998","journal-title":"J. Occup. Health"},{"key":"10.1016\/j.yrtph.2022.105157_bib18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1539\/joh.40.118","article-title":"Occupational leukoderma in workers engaged in 4-(p-hydroxyphenyl)-2-butanone manufacturing","volume":"40","author":"Fukuda","year":"1998","journal-title":"J. Occup. Health"},{"key":"10.1016\/j.yrtph.2022.105157_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/837042","article-title":"Properties of resveratrol: In vitro and in vivo studies about metabolism, bioavailability, and biological effects in animal models and humans","author":"Gambini","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.yrtph.2022.105157_bib20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-0536.1979.tb04853.x","article-title":"Detection of environmental depigmenting substances","volume":"5","author":"Gellin","year":"1979","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.yrtph.2022.105157_bib21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4103\/0019-5154.70680","article-title":"Chemical leukoderma: what's new on etiopathological and clinical aspects?","volume":"55","author":"Ghosh","year":"2010","journal-title":"Indian J. Dermatol."},{"key":"10.1016\/j.yrtph.2022.105157_bib22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2133.2008.08815.x","article-title":"Chemical leukoderma: a clinico-aetiological study of 864 cases in the perspective of a developing country","volume":"160","author":"Ghosh","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.yrtph.2022.105157_bib23","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.0906-6705.2005.00309.x","article-title":"Effective inhibition of melanosome transfer to keratinocytes by lectins and niacinamide is reversible","volume":"14","author":"Graetens","year":"2005","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.yrtph.2022.105157_bib24","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0891-5849(92)90184-I","article-title":"Antioxidant potential of ferulic acid","volume":"13","author":"Graf","year":"1992","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.yrtph.2022.105157_bib25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/cosmetics4030031","article-title":"In vitro methods for predicting chemical leukoderma caused by quasi-drug cosmetics","volume":"4","author":"Gu","year":"2017","journal-title":"Cosmetics"},{"issue":"1","key":"10.1016\/j.yrtph.2022.105157_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1046\/j.1365-2133.2002.04834.x","article-title":"The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer","volume":"147","author":"Hakozaki","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.yrtph.2022.105157_bib27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/toxsci\/kft080","article-title":"Uses of human in vitro skin models for accurate and ethical risk assessment: metabolic considerations","volume":"133","author":"Hewitt","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2022.105157_bib28","series-title":"4-(4-Hydroxyphenyl)butan-2-one","author":"IFRA Standard Amendment 49","year":"2020"},{"key":"10.1016\/j.yrtph.2022.105157_bib29","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.chemosphere.2019.06.185","article-title":"A unique system that can sensitively assess the risk of chemical leukoderma by using murine tail skin","volume":"235","author":"Iida","year":"2019","journal-title":"Chemosphere"},{"key":"10.1016\/j.yrtph.2022.105157_bib30","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/1346-8138.15878","article-title":"Rhododendrol-induced leukoderma update II: pathophysiology, mechanisms, risk evaluation, and possible mechanism-based treatments in comparison with vitiligo","volume":"48","author":"Inoue","year":"2021","journal-title":"J. Dermatol."},{"issue":"1","key":"10.1016\/j.yrtph.2022.105157_bib31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jdermsci.2015.07.007","article-title":"A convenient method to differentiate phenolic skin whitening tyrosinase inhibitors from leukoderma-inducing phenols","volume":"80","author":"Ito","year":"2015","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.yrtph.2022.105157_bib32","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3390\/ijms19020552","article-title":"Biochemical mechanism of rhododendrol-induced leukoderma","volume":"19","author":"Ito","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yrtph.2022.105157_bib33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/pcmr.12363","article-title":"Tyrosinase-catalyzed metabolism of rhododendrol (RD) in B16 melanoma cells: production of RD-pheomelanin and covalent binding with thiol proteins","volume":"28","author":"Ito","year":"2014","journal-title":"Pigm. Cell Melanoma Res."},{"key":"10.1016\/j.yrtph.2022.105157_bib34","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1021\/acs.chemrestox.7b00006","article-title":"The tyrosinase-catalyzed oxidation of the leukoderma-inducing agent raspberry ketone produces (E)-4-3-(3-oxo-1-butenyl)-1,2-benzoquinone: implications for melanocyte toxicity","volume":"30","author":"Ito","year":"2017","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.yrtph.2022.105157_bib35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/pcmr.12556","article-title":"The potent pro-oxidant activity of rhododendrol-eumelanin induces cysteine depletion in B16 melanoma cells","volume":"30","author":"Ito","year":"2017","journal-title":"Pigm. Cell Melanoma Res."},{"key":"10.1016\/j.yrtph.2022.105157_bib36","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/pcmr.12808","article-title":"Tyrosinase-catalyzed oxidation of resveratrol produces a highly reactive ortho-quinone: implications for melanocyte toxicity","volume":"32","author":"Ito","year":"2019","journal-title":"Pigm. Cell Melanoma Res."},{"key":"10.1016\/j.yrtph.2022.105157_bib37","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.3390\/ijms21176080","article-title":"Chemical reactivities of ortho-quinones produced in living organisms: fate of quinonoid products formed by tyrosinase and phenoloxidase action on phenols and catechols","volume":"21","author":"Ito","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yrtph.2022.105157_bib38","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/1523-1747.ep12701679","article-title":"Mechanism of depigmentation by hydroquinone","volume":"62","author":"Jimbow","year":"1974","journal-title":"J. Invest. Dermatol"},{"key":"10.1016\/j.yrtph.2022.105157_bib39","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jdermsci.2014.07.001","article-title":"Depigmentation caused by application of the active brightening material, rhododendrol, is related to tyrosinase activity at a certain threshold","volume":"76","author":"Kasamatsu","year":"2014","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.yrtph.2022.105157_bib40","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2131\/jts.39.615","article-title":"Depigmentation of the skin induced by 4-(4-hydroxyphenyl)-2-butanol is spontaneously re-pigmented in brown and black Guinea pigs","volume":"39","author":"Kuroda","year":"2014","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2022.105157_bib41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4062\/biomolther.2013.081","article-title":"Inhibitory effects of resveratrol on melanin synthesis in ultraviolet B-induced pigmentation in Guinea pig skin","volume":"22","author":"Lee","year":"2014","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.yrtph.2022.105157_bib42","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.3390\/ijms12084819","article-title":"Evaluation of in vitro and in vivo depigmenting activity of raspberry ketone from Rheum officinale","volume":"12","author":"Lin","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yrtph.2022.105157_bib43","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jsbmb.2009.05.011","article-title":"Expression profiles of phases 1 and 2 metabolizing enzymes in human skin and the reconstructed skin models Episkin and full thickness model from Episkin","volume":"116","author":"Luu-The","year":"2009","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.yrtph.2022.105157_bib44","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijpharm.2006.09.020","article-title":"The \u2018\u2018in vitro\u201d percutaneous penetration of three antioxidant compounds","volume":"331","author":"Marti-Mestres","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.yrtph.2022.105157_bib45","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/archderm.1980.01640340082022","article-title":"Perioral leukoderma simulating vitiligo from use of a toothpaste containing cinnamic aldehyde","volume":"116","author":"Mathias","year":"1980","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.yrtph.2022.105157_bib46","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.yrtph.2016.08.005","article-title":"Risk assessment of skin lightening cosmetics containing hydroquinone","volume":"81","author":"Matsumoto","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2022.105157_bib47","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/1346-8138.15835","article-title":"Rhododendrol-induced leukoderma update 1: clinical findings and treatment","volume":"48","author":"Matsunaga","year":"2021","journal-title":"J. Dermatol."},{"key":"10.1016\/j.yrtph.2022.105157_bib48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12302-015-0044-7","article-title":"Oxidative transformation processes and products of para-phenylenediamine (PPD) and para-toluenediamine (PTD) \u2013 a review","volume":"27","author":"Meyer","year":"2015","journal-title":"Environ. Sci. Eur."},{"key":"10.1016\/j.yrtph.2022.105157_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115359","article-title":"Metabolism of skin-absorbed resveratrol into it glucuronidized form in mouse skin","volume":"9","author":"Murakami","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.yrtph.2022.105157_bib50","series-title":"The Mechanism of Melanocytes- Specific Cytotoxicity Induced by Phenol Compounds Having a Prooxidant Effect, Relating to the Appearance of Leukoderma","first-page":"1","author":"Nagata","year":"2015"},{"key":"10.1016\/j.yrtph.2022.105157_bib51","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/1346-8138.12744","article-title":"Guide for medical professionals (i.e., dermatologists) for the management of Rhododenol-induced leukoderma","volume":"42","author":"Nishigori","year":"2015","journal-title":"J. Dermatol."},{"key":"10.1016\/j.yrtph.2022.105157_bib52","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/pcmr.12904","article-title":"Genome-wide association study identifies CDH13 as a susceptibility gene for rhododendrol-induced leukoderma","volume":"33","author":"Okamura","year":"2020","journal-title":"Pigm. Cell Melanoma Res."},{"key":"10.1016\/j.yrtph.2022.105157_bib53","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/jama.1939.72800350003010a","article-title":"Occupational leukoderma","volume":"113","author":"Oliver","year":"1939","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.yrtph.2022.105157_bib54","series-title":"RIFM Report Number 73036","article-title":"4-(p-hydroxyphenyl)-2-butanone: depigmentation assessment study after topical dermal dose administration in miniature swine","year":"2017"},{"key":"10.1016\/j.yrtph.2022.105157_bib55","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1021\/jf011295i","article-title":"Sulfated ferulic acid is the main in vivo metabolite found after short-term ingestion of free ferulic acid in rats","volume":"50","author":"Rondini","year":"2002","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.yrtph.2022.105157_bib56","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0378-5173(00)00358-6","article-title":"In vitro and in vivo evaluation of caffeic acid and ferulic acids as topical photoprotective agents","volume":"199","author":"Saija","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.yrtph.2022.105157_bib57","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jaad.2018.03.063","article-title":"Acquired disorders with depigmentation: a systematic approach to vitiliginoid conditions","volume":"80","author":"Saleem","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.yrtph.2022.105157_bib58","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/pcmr.12269","article-title":"Rhododendrol, a depigmentation-inducing phenolic compound, exerts melanocyte cytotoxicity via a tyrosinase-dependent mechanism","volume":"27","author":"Sasaki","year":"2014","journal-title":"Pigm. Cell Melanoma Res."},{"key":"10.1016\/j.yrtph.2022.105157_bib59","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2174\/1386207320666170602090448","article-title":"Caffeic acid in dermatologic formulations: In vitro release profile and skin absorption","volume":"20","author":"Spagnol","year":"2017","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.yrtph.2022.105157_bib60","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/00498258209052463","article-title":"The metabolism of 4-(4-hydroxyphenyl)butan-2-one (raspberry ketone) in rats, Guinea-pigs and rabbits","volume":"12","author":"Sportstol","year":"1982","journal-title":"Xenobiotica"},{"key":"10.1016\/j.yrtph.2022.105157_bib61","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.toxlet.2018.04.011","article-title":"A study of inter-individual variability in the Phase II metabolism of xenobiotics in human skin","volume":"292","author":"Spriggs","year":"2018","journal-title":"Toxicol. Lett."},{"issue":"2","key":"10.1016\/j.yrtph.2022.105157_bib62","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/0300985811402846","article-title":"Swine as models in biomedical research and toxicology testing","volume":"49","author":"Swindle","year":"2012","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.yrtph.2022.105157_bib63","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jdermsci.2015.01.002","article-title":"An immune pathological and ultrastructural skin analysis for rhododenol-induced leukoderma patients","volume":"77","author":"Tanemura","year":"2015","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.yrtph.2022.105157_bib64","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jdermsci.2015.02.001","article-title":"Biochemical, cytological, and immunological mechanism of rhododendrol-induced leukoderma","volume":"72","author":"Tokura","year":"2015","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.yrtph.2022.105157_bib65","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.fct.2009.06.002","article-title":"Safety studies conducted on high-purity trans-resveratrol in experimental animals","volume":"47","author":"Williams","year":"2009","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2022.105157_bib66","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.yrtph.2009.09.006","article-title":"A framework for using structural, reactivity, metabolic and physiochemical similarity to evaluate the suitability of analogs for SAR-based toxicological assessments","volume":"56","author":"Wu","year":"2010","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2022.105157_bib67","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jdermsci.2015.01.006","article-title":"4-(4-Hydroxyphenyl)-2-butanol (rhododendron) activates the autophagy-lysosome pathway in melanocytes: insights into the mechanisms of rhododendrol-induced leukoderma","volume":"77","author":"Yang","year":"2015","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.yrtph.2022.105157_bib68","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1023\/A:1021414129280","article-title":"Human, rat, and mouse metabolism of resveratrol","volume":"19","author":"Yu","year":"2002","journal-title":"Pharmaceut. Res."},{"key":"10.1016\/j.yrtph.2022.105157_bib69","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/10286020310001617129","article-title":"Metabolism of ferulic acid in rats","volume":"7","author":"Zhang","year":"2005","journal-title":"J. Asian Nat. Prod. Res."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230022000447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230022000447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:32:50Z","timestamp":1759494770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230022000447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":69,"alternative-id":["S0273230022000447"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2022.105157","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A framework to mitigate the risk of chemical leukoderma: Consumer products","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2022.105157","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105157"}}